EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
FDA premarket approval P920031 · decided 1996-10-02
Approval details
- PMA number
- P920031
- Trade name
- EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
- Generic name
- CYCLOSPORINE
- Applicant
- Dade Behring, Inc.
- Date received
- 1992-06-29
- Decision date
- 1996-10-02
- Days to decision
- 1556 days
- Decision code
- APRL
- Product code
- MKW
- Advisory committee
- Clinical Toxicology
- Expedited review
- No
- Location
- Newark, DE
- Statement
- APPROVAL FOR THE EMIT(R) 2000 CYCLOSPORINE SPECIFIC ASSAY. THE DEVICE IS INDICATED FOR IN VITRO DIAGNOSTIC USE ON THE ROCHE DIAGNOSTICS SYSTEMS COBAS MIRA, COBAS MIRA S, AND COBAS MIRA PLUS CHEMISTRY SYSTEMS FOR THE QUANTITATIVE ANALYSIS OF CYCLOSPORINE (CSA) IN HUMAN WHOLE BLOOD AS AN AID IN THE MANAGEMENT OF CYCLOSPORINE THERAPY IN KIDNEY, HEART, AND LIVER TRANSPLANT PATIENTS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.